EKLD:XETRA:XETRA-BNP Paribas Easy MSCI USA SRI S-Series PAB 5% Capped UCITS ETF Capitalisation (USD)

ETF | Others |

Last Closing

USD 21.97

Change

0.00 (0.00)%

Market Cap

USD 0.53B

Volume

1.24K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Replicate the performance of the MSCI USA SRI S-Series 5% Capped, including fluctuations, and to maintain the Tracking Error between the sub-fund and the index below 1%. For that purpose, the manager of the sub-fund"s portfolio will be able to switch between the two index replication methods described below, to ensure optimum management of the sub-fund. At least, 51% of the assets will be invested at all times in equities. The sub-fund will not invest more than 10% of its net assets in shares or units issued by UCITS or other UCIs.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-28 )

ETFs Containing EKLD:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 13.34% 65% D 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.34% 65% D 67% D+
Trailing 12 Months  
Capital Gain 28.27% 84% B 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 28.27% 84% B 82% B
Trailing 5 Years  
Capital Gain 103.31% 97% N/A 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 103.31% 97% N/A 94% A
Average Annual (5 Year Horizon)  
Capital Gain 15.13% N/A N/A 84% B
Dividend Return 15.13% N/A N/A 83% B
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 19.25% N/A N/A 34% F
Risk Adjusted Return 78.60% N/A N/A 82% B
Market Capitalization 0.53B 67% D+ 59% D-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike